Early detection of cancer using biomarkers obtained from blood or other easily accessible tissues would have a significant impact on reducing cancer mortality. However, identifying new blood-based biomarkers has been hindered by the dynamic complexity of the human plasma proteome, confounded by genetic and environmental variability, and the scarcity of high quality controlled samples. In this report, we discuss a new paradigm for biomarker discovery through the use of mouse models. Inbred mouse models of cancer recapitulate many critical features of human cancer, while eliminating sources of environmental and genetic variability. The ability to collect samples from highly matched cases and controls under identical conditions further reduces...
Selection of mouse models of cancer is often based simply on availability of a mouse strain and a kn...
A proof-of-concept demonstration of the use of label-free quantitative glycoproteomics for biomarker...
Objectives: Mouse models of prostate cancer are used to test the contribution of individual genes to...
The complexity of the human plasma proteome represents a substantial challenge for biomarker discove...
Item does not contain fulltextThe laboratory mouse is widely considered as a valid and affordable mo...
<div><p>The most cancer-specific biomarkers in blood are likely to be proteins shed directly by the ...
Mice have long been used as models for the study of human cancer. The National Cancer Institute has ...
The complexity and heterogeneity of the human plasma proteome have presented significant challenges ...
Many mouse models have been created to study hematopoietic cancer types. There are over thirty hemat...
Abstract Early detection of cancer is vital for the best chance of successful treatment, but half of...
Circulating tumor cells (CTC) are emerging as a powerful prognostic and predictive biomarker in seve...
As the number of cancer survivors treated with radiation as a part of their therapy regimen is const...
Prostate cancer is relatively unique to man. There is no naturally occurring prostate cancer in the ...
Abstract Background Transgenic mouse tumor models have the advantage of facilitating controlled in v...
Genetic differences among individuals contribute to differential susceptibility to cancer and, undou...
Selection of mouse models of cancer is often based simply on availability of a mouse strain and a kn...
A proof-of-concept demonstration of the use of label-free quantitative glycoproteomics for biomarker...
Objectives: Mouse models of prostate cancer are used to test the contribution of individual genes to...
The complexity of the human plasma proteome represents a substantial challenge for biomarker discove...
Item does not contain fulltextThe laboratory mouse is widely considered as a valid and affordable mo...
<div><p>The most cancer-specific biomarkers in blood are likely to be proteins shed directly by the ...
Mice have long been used as models for the study of human cancer. The National Cancer Institute has ...
The complexity and heterogeneity of the human plasma proteome have presented significant challenges ...
Many mouse models have been created to study hematopoietic cancer types. There are over thirty hemat...
Abstract Early detection of cancer is vital for the best chance of successful treatment, but half of...
Circulating tumor cells (CTC) are emerging as a powerful prognostic and predictive biomarker in seve...
As the number of cancer survivors treated with radiation as a part of their therapy regimen is const...
Prostate cancer is relatively unique to man. There is no naturally occurring prostate cancer in the ...
Abstract Background Transgenic mouse tumor models have the advantage of facilitating controlled in v...
Genetic differences among individuals contribute to differential susceptibility to cancer and, undou...
Selection of mouse models of cancer is often based simply on availability of a mouse strain and a kn...
A proof-of-concept demonstration of the use of label-free quantitative glycoproteomics for biomarker...
Objectives: Mouse models of prostate cancer are used to test the contribution of individual genes to...